Open Access Email this article to a friend

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial

Hiroyuki Konaka*, Shin Egawa, Shiro Saito, Atsunori Yorozu, Hiroyuki Takahashi, Keiko Miyakoda, Masanori Fukushima, Takushi Dokiya, Hidetoshi Yamanaka, Nelson N Stone and Mikio Namiki

BMC Cancer 2012, 12:110  doi:10.1186/1471-2407-12-110

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?